Advanced search
Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 53, 2023 - Issue 3
Submit an article Journal homepage
203
Views
0
CrossRef citations to date
0
Altmetric
Clinical Pharmacokinetics and Metabolism

Metabolism, pharmacokinetics and excretion of [14C]dimethyl fumarate in healthy volunteers: an example of xenobiotic biotransformation following endogenous metabolic pathways

Lin XuClinical Pharmacology and Pharmacometrics, Biogen, Cambridge, MA, USACorrespondence[email protected]
View further author information
,
Chi-Chi PengClinical Pharmacology and Pharmacometrics, Biogen, Cambridge, MA, USAView further author information
,
Kate DawsonClinical Pharmacology and Pharmacometrics, Biogen, Cambridge, MA, USAView further author information
,
Scott StecherClinical Pharmacology and Pharmacometrics, Biogen, Cambridge, MA, USAView further author information
,
James WoodworthClinical Pharmacology and Pharmacometrics, Biogen, Cambridge, MA, USAView further author information
&
Chandra PrakashClinical Pharmacology and Pharmacometrics, Biogen, Cambridge, MA, USAView further author information
Pages 163-172 | Received 02 Apr 2023, Accepted 21 May 2023, Published online: 01 Jun 2023

References

  • Bar-Or A, Gold R, Kappos L, Arnold DL, Giovannoni G, Selmaj K, O'Gorman J, Stephan M, Dawson KT. 2013. Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the DEFINE study. J Neurol. 260(9):2297–2305.
  • Bircher J, Preisig R. 1981. Exhalation of isotopic CO2. Methods Enzymol. 77:3–9.
  • Bulusu V, Jayaraman V, Balaram H. 2011. Metabolic fate of fumarate, a side product of the purine salvage pathway in the intraerythrocytic stages of Plasmodium falciparum. J Biol Chem. 286(11):9236–9245.
  • Dibbert S, Clement B, Skak-Nielsen T, Mrowietz U, Rostami-Yazdi M. 2013. Detection of fumarate-glutathione adducts in the portal vein blood of rats: evidence for rapid dimethylfumarate metabolism. Arch Dermatol Res. 305(5):447–451.
  • Gopal S, Mikulskis A, Gold R, Fox RJ, Dawson KT, Amaravadi L. 2017. Evidence of activation of the Nrf2 pathway in multiple sclerosis patients treated with delayed-release dimethyl fumarate in the Phase 3 DEFINE and CONFIRM studies. Mult Scler. 23(14):1875–1883.
  • Havrdova E, Hutchinson M, Kurukulasuriya NC, Raghupathi K, Sweetser MT, Dawson KT, Gold R. 2013. Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM. Evaluation of: Gold R, Kappos L, Arnold D, 2012. and Fox RJ, Miller DH, Phillips JT, et al. Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. Expert opin pharmacother. 14(15):2145–2156. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med 2012;367:1087-97. Expert Opin Pharmacother. 14(15):2145–2156.
  • Henderson R. 2006. Carbon dioxide measures up as a real hazard. Occup Health Saf. 75(7):64. 68–69.
  • Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, et al. 2008. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet. 372(9648):1463–1472.
  • Kreisel W, Volk BA, Buchsel R, Reutter W. 1980. Different half-lives of the carbohydrate and protein moieties of a 110,000-dalton glycoprotein isolated from plasma membranes of rat liver. Proc Natl Acad Sci U S A. 77(4):1828–1831.
  • Kretzschmar B, Pellkofer H, Weber MS. 2016. The use of oral disease-modifying therapies in multiple sclerosis. Curr Neurol Neurosci Rep. 16(4):38.
  • Litjens NH, Burggraaf J, van Strijen E, van Gulpen C, Mattie H, Schoemaker RC, van Dissel JT, Thio HB, Nibbering PH. 2004. Pharmacokinetics of oral fumarates in healthy subjects. Br J Clin Pharmacol. 58(4):429–432.
  • Malaisse WJ, Ladriere L, Jijakli H, Laatikainen R, Niemitz M, Verbruggen I, Biesernans M, Willem R. 1998. Metabolism of the dimethyl ester of [2,3-(13)C]succinic acid in rat hepatocytes. Mol Cell Biochem. 189(1-2):137–144.
  • Penner N, Klunk LJ, Prakash C. 2009. Human radiolabeled mass balance studies: objectives, utilities and limitations. Biopharm Drug Dispos. 30(4):185–203. eng.
  • Roffey SJ, Obach RS, Gedge JI, Smith DA. 2007. What is the objective of the mass balance study? A retrospective analysis of data in animal and human excretion studies employing radiolabeled drugs. Drug Metab Rev. 39(1):17–43.
  • Sheikh SI, Nestorov I, Russell H, O'Gorman J, Huang R, Milne GL, Scannevin RH, Novas M, Dawson KT. 2013. Tolerability and pharmacokinetics of delayed-release dimethyl fumarate administered with and without aspirin in healthy volunteers. Clin Ther. 35(10):1582–1594 e1589.
  • Tullman MJ. 2013. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 19(2 Suppl):S15–S20.
  • Wang J, Li-Chan XX, Atherton J, Deng L, Espina R, Yu L, Horwatt P, Ross S, Lockhead S, Ahmad S, et al. 2010. Characterization of HKI-272 covalent binding to human serum albumin. Drug Metab Dispos. 38(7):1083–1093.
  • Watkins PB. 1991. Breath tests as noninvasive assays of P450s. Methods Enzymol. 206:517–522.
  • Werdenberg D, Joshi R, Wolffram S, Merkle HP, Langguth P. 2003. Presystemic metabolism and intestinal absorption of antipsoriatic fumaric acid esters. Biopharm Drug Dispos. 24(6):259–273.
  • Xu L, Dawson K, Woodworth J, Yang L, J Klunk L, Stecher S, Prakash C. 2009. Metabolism and Excretion of BG12 in Rats and Humans Following Oral Administration of a Single Oral Dose of [14C]BG12. 16th North American Regional International Society for the Study of Xenobiotics (ISSX) Meeting; Baltimore, Maryland, US.
  • Zhang TM, Sener A, Malaisse WJ. 1994. Metabolic effects and fate of succinic acid methyl esters in rat hepatocytes. Arch Biochem Biophys. 314(1):186–192.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.